help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

This version published online on January 24, 2008
Endocrinology, doi:10.1210/en.2007-1686
A more recent version of this article appeared on May 1, 2008
This Article
Right arrow Author Manuscript (PDF)
Right arrow All Versions of this Article:
149/5/2477    most recent
Author Manuscript (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Romero, D. G.
Right arrow Articles by Gomez-Sanchez, C. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Romero, D. G.
Right arrow Articles by Gomez-Sanchez, C. E.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*UniGene
*Compound via MeSH
*Substance via MeSH

Submitted on December 6, 2007
Accepted on January 17, 2008

MicroRNA-21 Increases Aldosterone Secretion and Proliferation in H295R Human Adrenocortical Cells

Damian G. Romero*, Maria W. Plonczynski, Cristian A. Carvajal, Elise P. Gomez-Sanchez, and Celso E. Gomez-Sanchez

Division of Endocrinology, G.V. (Sonny) Montgomery VA Medical Center, and Departments of Medicine and Pharmacology and Toxicology, University of Mississippi Medical Center, Jackson, MS 39216, Department of Endocrinology, Faculty of Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile

* To whom correspondence should be addressed. E-mail: dromero{at}medicine.umsmed.edu.

MicroRNAs (miRNAs) are endogenous small non-coding RNAs which decrease the expression levels of specific genes by translational repression, sequestration and degradation of their mRNAs. Angiotensin II is an important modulator of adrenal zona glomerulosa cell physiology, including steroidogenesis and proliferation among many other physiological processes. Since each miRNA may regulate the expression levels of multiple genes, thereby resembling the transcription regulatory networks triggered by transcription factors, we hypothesize that specific miRNAs may be involved in angiotensin II-mediated adrenocortical cell physiology. The human adrenocortical cell line H295R is the only adrenal cell line available with a steroid secretion pattern and regulation similar to freshly isolated adrenocortical cells. We screened for miRNAs regulated by angiotensin II in H295R cells and found that mir-21 expression levels were specifically modulated by angiotensin II. Angiotensin II-time dependently increased mir-21 expression reaching a 4.4-fold induction after 24 h. Angiotensin II-mediated mir-21 expression resulted in biologically active mir-21, determined using a fusion mRNA reporter system carrying mir-21 target sequences in its 3' UTR. Upregulation of mir-21 intracellular levels increased aldosterone secretion but not cortisol. Elevation of mir-21 levels also increased cell proliferation in H295R cells. In summary, mir-21 is an endogenously expressed miRNA in human adrenal cells. Mir-21 expression is upregulated by angiotensin II and its overexpression caused an increase in aldosterone secretion and cell proliferation. Alterations in mir-21 expression levels or function may be involved in dysregulation of angiotensin II signaling and abnormal aldosterone secretion by adrenal glands in humans.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2008 by The Endocrine Society